282 related articles for article (PubMed ID: 26458122)
1. Potential structural and functional biomarkers of upper motor neuron dysfunction in ALS.
Grieve SM; Menon P; Korgaonkar MS; Gomes L; Foster S; Kiernan MC; Vucic S
Amyotroph Lateral Scler Frontotemporal Degener; 2015; 17(1-2):85-92. PubMed ID: 26458122
[TBL] [Abstract][Full Text] [Related]
2. Novel approaches to assessing upper motor neuron dysfunction in motor neuron disease/amyotrophic lateral sclerosis: IFCN handbook chapter.
Dharmadasa T; Pavey N; Tu S; Menon P; Huynh W; Mahoney CJ; Timmins HC; Higashihara M; van den Bos M; Shibuya K; Kuwabara S; Grosskreutz J; Kiernan MC; Vucic S
Clin Neurophysiol; 2024 Jul; 163():68-89. PubMed ID: 38705104
[TBL] [Abstract][Full Text] [Related]
3. Cortical excitability distinguishes ALS from mimic disorders.
Vucic S; Cheah BC; Yiannikas C; Kiernan MC
Clin Neurophysiol; 2011 Sep; 122(9):1860-6. PubMed ID: 21382747
[TBL] [Abstract][Full Text] [Related]
4. Effect of racial background on motor cortical function as measured by threshold tracking transcranial magnetic stimulation.
Suzuki YI; Ma Y; Shibuya K; Misawa S; Suichi T; Tsuneyama A; Nakamura K; Matamala JM; Dharmadasa T; Vucic S; Fan D; Kiernan MC; Kuwabara S
J Neurophysiol; 2021 Sep; 126(3):840-844. PubMed ID: 34406906
[TBL] [Abstract][Full Text] [Related]
5. Early diagnosis of amyotrophic lateral sclerosis by threshold tracking and conventional transcranial magnetic stimulation.
Tankisi H; Nielsen CS; Howells J; Cengiz B; Samusyte G; Koltzenburg M; Blicher JU; Møller AT; Pugdahl K; Fuglsang-Frederiksen A; de Carvalho M; Bostock H
Eur J Neurol; 2021 Sep; 28(9):3030-3039. PubMed ID: 34233060
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic utility of cortical excitability studies in amyotrophic lateral sclerosis.
Geevasinga N; Menon P; Yiannikas C; Kiernan MC; Vucic S
Eur J Neurol; 2014 Dec; 21(12):1451-7. PubMed ID: 24698287
[TBL] [Abstract][Full Text] [Related]
7. Reduction in short interval intracortical inhibition from the early stage reflects the pathophysiology in amyotrophic lateral sclerosis: A meta-analysis study.
Higashihara M; Pavey N; Menon P; van den Bos M; Shibuya K; Kuwabara S; Kiernan MC; Koinuma M; Vucic S
Eur J Neurol; 2024 Jul; 31(7):e16281. PubMed ID: 38504632
[TBL] [Abstract][Full Text] [Related]
8. Cortical hyperexcitability precedes lower motor neuron dysfunction in ALS.
Menon P; Kiernan MC; Vucic S
Clin Neurophysiol; 2015 Apr; 126(4):803-9. PubMed ID: 25227219
[TBL] [Abstract][Full Text] [Related]
9. Cortical thickness in ALS: towards a marker for upper motor neuron involvement.
Walhout R; Westeneng HJ; Verstraete E; Hendrikse J; Veldink JH; van den Heuvel MP; van den Berg LH
J Neurol Neurosurg Psychiatry; 2015 Mar; 86(3):288-94. PubMed ID: 25121571
[TBL] [Abstract][Full Text] [Related]
10. A new parameter to discriminate amyotrophic lateral sclerosis patients from healthy participants by motor cortical excitability changes.
Cengiz B; Kuruoğlu R
Muscle Nerve; 2020 Mar; 61(3):354-362. PubMed ID: 31875983
[TBL] [Abstract][Full Text] [Related]
11. Cortical hyperexcitability and disease spread in amyotrophic lateral sclerosis.
Menon P; Geevasinga N; van den Bos M; Yiannikas C; Kiernan MC; Vucic S
Eur J Neurol; 2017 Jun; 24(6):816-824. PubMed ID: 28436181
[TBL] [Abstract][Full Text] [Related]
12. Impairment of triad conditioned facilitation in amyotrophic lateral sclerosis.
Groiss SJ; Mochizuki H; Hanajima R; Trenado C; Nakatani-Enomoto S; Otani K; Ugawa Y
Amyotroph Lateral Scler Frontotemporal Degener; 2017 Nov; 18(7-8):604-610. PubMed ID: 28485644
[TBL] [Abstract][Full Text] [Related]
13. Cortical excitability testing distinguishes Kennedy's disease from amyotrophic lateral sclerosis.
Vucic S; Kiernan MC
Clin Neurophysiol; 2008 May; 119(5):1088-96. PubMed ID: 18313980
[TBL] [Abstract][Full Text] [Related]
14. Regional motor cortex dysfunction in amyotrophic lateral sclerosis.
Menon P; Yiannikas C; Kiernan MC; Vucic S
Ann Clin Transl Neurol; 2019 Aug; 6(8):1373-1382. PubMed ID: 31402622
[TBL] [Abstract][Full Text] [Related]
15. Transcallosal inhibition in amyotrophic lateral sclerosis.
Wittstock M; Wolters A; Benecke R
Clin Neurophysiol; 2007 Feb; 118(2):301-7. PubMed ID: 17140846
[TBL] [Abstract][Full Text] [Related]
16. Transcranial magnetic stimulation (TMS): compared sensitivity of different motor response parameters in ALS.
Pouget J; Trefouret S; Attarian S
Amyotroph Lateral Scler Other Motor Neuron Disord; 2000 Jun; 1 Suppl 2():S45-9. PubMed ID: 11464941
[TBL] [Abstract][Full Text] [Related]
17. Utility of transcranial magnetic stimulation in delineating amyotrophic lateral sclerosis pathophysiology.
Vucic S; Kiernan MC
Handb Clin Neurol; 2013; 116():561-75. PubMed ID: 24112924
[TBL] [Abstract][Full Text] [Related]
18. [Objective markers for upper motor neuron involvement in amyotrophic lateral sclerosis].
Iwata NK
Brain Nerve; 2007 Oct; 59(10):1053-64. PubMed ID: 17969345
[TBL] [Abstract][Full Text] [Related]
19. Defining the mechanisms that underlie cortical hyperexcitability in amyotrophic lateral sclerosis.
Vucic S; Cheah BC; Kiernan MC
Exp Neurol; 2009 Nov; 220(1):177-82. PubMed ID: 19716820
[TBL] [Abstract][Full Text] [Related]
20. Three different short-interval intracortical inhibition methods in early diagnosis of amyotrophic lateral sclerosis.
Tankisi H; Pia H; Strunge K; Howells J; Cengiz B; Samusyte G; Koltzenburg M; Fuglsang-Frederiksen A; Bostock H
Amyotroph Lateral Scler Frontotemporal Degener; 2023 Feb; 24(1-2):139-147. PubMed ID: 35899374
[No Abstract] [Full Text] [Related]
[Next] [New Search]
